Published in Stem Cell Res Ther on April 30, 2013
SVF (Adipose Tissue Derived MSC) Based Therapy for CKD. (StemCell&CKD) | NCT03939741
Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells (2014) 1.21
Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives. Stem Cells Transl Med (2013) 0.96
Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma. Clin Exp Allergy (2014) 0.81
Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development. Stem Cells Dev (2014) 0.78
Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion. Cytotherapy (2016) 0.77
Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Transl Med (2015) 0.77
Therapeutic doses of multipotent stromal cells from minimal adipose tissue. Stem Cell Rev (2014) 0.76
Extensive characterization of feline intra-abdominal adipose-derived mesenchymal stem cells. J Vet Sci (2017) 0.76
Regenerating a kidney in a lymph node. Pediatr Nephrol (2015) 0.75
Allogeneic Mesenchymal Stem Cell Transplantation in Dogs With Keratoconjunctivitis Sicca. Cell Med (2016) 0.75
Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review. Stem Cell Res Ther (2015) 0.75
Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy. Stem Cells Int (2016) 0.75
Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats. J Vet Intern Med (2015) 0.75
Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome. Stem Cell Res Ther (2017) 0.75
Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol (2005) 6.71
Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol (2004) 3.41
Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol (2005) 3.12
Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells (2006) 3.02
Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol (2008) 2.35
Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int (2006) 1.82
Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells (2009) 1.71
Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J (2005) 1.45
Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells (2012) 1.36
Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One (2012) 1.28
Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). J Am Vet Med Assoc (1987) 1.19
VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med (2008) 1.14
The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev (2009) 1.12
Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease. Nephrology (Carlton) (2007) 1.12
Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant (2009) 1.10
Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation. Res Vet Sci (2010) 1.06
The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury. Biomaterials (2012) 1.05
Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model. Clin Sci (Lond) (2011) 1.04
Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol (2010) 1.03
Adipose-derived mesenchymal stem cells: biology and potential applications. Adv Biochem Eng Biotechnol (2013) 1.03
Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Ren Fail (2010) 1.01
Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc (2009) 0.99
Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods (2012) 0.98
Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney. Clin Exp Nephrol (2012) 0.95
The therapeutic effect of human adult stem cells derived from adipose tissue in endotoxemic rat model. Int J Med Sci (2012) 0.94
Histomorphometry of feline chronic kidney disease and correlation with markers of renal dysfunction. Vet Pathol (2012) 0.93
Improvement of kidney failure with fetal kidney precursor cell transplantation. Transplantation (2007) 0.93
Mesenchymal stem cell therapy for chronic renal failure. Expert Opin Biol Ther (2010) 0.92
The use of stem cells in kidney disease. Curr Opin Organ Transplant (2009) 0.91
In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells. J Feline Med Surg (2012) 0.89
Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study. J Feline Med Surg (2011) 0.88
Use of plasma clearance of iohexol for estimating glomerular filtration rate in cats. Am J Vet Res (2001) 0.87
Suspension medium influences interaction of mesenchymal stromal cells with endothelium and pulmonary toxicity after transplantation in mice. Cytotherapy (2010) 0.86
Stem cell therapy for the kidney? Am J Ther (2009) 0.85
Disposition of plasma creatinine in non-azotaemic and moderately azotaemic cats. J Feline Med Surg (2006) 0.82
Review article: Potential cellular therapies for renal disease: can we translate results from animal studies to the human condition? Nephrology (Carlton) (2009) 0.81
Stem cell therapy and regenerative medicine. Mayo Clin Proc (2009) 0.81
Glomerular filtration rate and renal scintigraphy. Clin Tech Small Anim Pract (2005) 0.80
Stem cells and the kidney: a new therapeutic tool? J Am Soc Nephrol (2006) 0.80
Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease. J Feline Med Surg (2012) 0.79
Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol (2005) 2.79
Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol (2009) 2.10
Present and future therapeutic strategies for melioidosis and glanders. Expert Rev Anti Infect Ther (2010) 1.45
Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. J Clin Invest (2006) 1.40
Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection. J Am Vet Med Assoc (2012) 1.39
Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. PLoS Negl Trop Dis (2009) 1.34
Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun (2005) 1.26
A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Infect Immun (2010) 1.26
Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrob Agents Chemother (2010) 1.08
Development of Burkholderia mallei and pseudomallei vaccines. Front Cell Infect Microbiol (2013) 1.08
Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes. Antiviral Res (2006) 1.07
A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model. J Immunol (2006) 1.06
Early interaction of Yersinia pestis with APCs in the lung. J Immunol (2005) 0.98
Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation. J Immunol (2009) 0.93
Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections. PLoS Pathog (2012) 0.93
Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med (2007) 0.93
Suppression of vaccine immunity by inflammatory monocytes. J Immunol (2012) 0.91
Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis. Vaccine (2009) 0.91
Consumption of rice bran increases mucosal immunoglobulin A concentrations and numbers of intestinal Lactobacillus spp. J Med Food (2012) 0.89
In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells. J Feline Med Surg (2012) 0.89
The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice. Infect Immun (2011) 0.89
Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensis. Microbes Infect (2010) 0.88
Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis. PLoS Negl Trop Dis (2012) 0.88
Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials (2008) 0.88
Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study. J Feline Med Surg (2011) 0.88
Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses. Cancer Immunol Immunother (2009) 0.88
Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia. Vaccine (2012) 0.86
Dietary rice bran promotes resistance to Salmonella enterica serovar Typhimurium colonization in mice. BMC Microbiol (2012) 0.86
Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Infect Immun (2013) 0.86
Growth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexes. Cancer Immunol Immunother (2003) 0.85
Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity. Int Immunopharmacol (2012) 0.85
Enhancing antimelanoma immune responses through apoptosis. Cancer Gene Ther (2003) 0.83
Serum concentrations of monocyte chemoattractant protein-1 in healthy and critically ill dogs. Vet Clin Pathol (2010) 0.82
Effects of chemotherapy on immune responses in dogs with cancer. J Vet Intern Med (2006) 0.80
Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease. J Feline Med Surg (2012) 0.79
Evaluation of the effects of hospital visit stress on physiologic variables in dogs. J Am Vet Med Assoc (2015) 0.79
Minimally invasive assessment of tumor angiogenesis by fine needle aspiration and flow cytometry. Angiogenesis (2010) 0.78
Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study. Vet Dermatol (2005) 0.78
Depletion of phagocytic myeloid cells triggers spontaneous T cell- and NK cell-dependent antitumor activity. Oncoimmunology (2012) 0.77
Sustained generation of tissue dendritic cells from cats using organ stromal cell cultures. Vet Immunol Immunopathol (2007) 0.76
Evaluation of a novel immunotherapy for treatment of chronic rhinitis in cats. J Feline Med Surg (2006) 0.75
Characterization of a Jumping Stereotypy in Gerbils (Meriones unguiculatus) and Assessment of Opaque Tubing Enrichment on Stereotypies and Breeding. J Am Assoc Lab Anim Sci (2022) 0.75
Subcutaneous fluid port-associated soft tissue sarcoma in a cat. J Feline Med Surg (2013) 0.75
Preliminary pharmacokinetics of intravenous and subcutaneous dolasetron and pharmacodynamics of subcutaneous dolasetron in healthy cats. J Feline Med Surg (2017) 0.75
Comparison of proliferative and immunomodulatory potential of adipose-derived mesenchymal stem cells from young and geriatric cats. J Feline Med Surg (2016) 0.75